SpectraCure AB (OSTO:SPEC) Total Receivables: kr1.77 Mil (As of Mar. 2026)


What is SpectraCure AB Total Receivables?

SpectraCure AB OSTO:SPEC +3.45% Total Receivables is kr1.77 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

SpectraCure AB's Total Receivables for the quarter that ended in Mar. 2026 was kr1.77 Mil.

SpectraCure AB Total Receivables Related Terms

SpectraCure AB Total Receivables Historical Data

* Premium members only.

The historical data trend for SpectraCure AB's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpectraCure AB Total Receivables Chart

SpectraCure AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 1.10 1.56 3.49 2.21

SpectraCure AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.05 56.63 3.11 2.21 1.77

SpectraCure AB Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of kr1.77 Mil mean?
SpectraCure AB (OSTO:SPEC) has a Total Receivables of kr1.77 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on SpectraCure AB and its competitors.
Is SpectraCure AB's Total Receivables too high?
SpectraCure AB's current Total Receivables is kr1.77 Mil.
How does SpectraCure AB's Total Receivables compare to ABT and SYK?
SpectraCure AB's Total Receivables of kr1.77 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on SpectraCure AB and its competitors. SpectraCure AB's current Total Receivables is kr1.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpectraCure AB stock overvalued right now?
SpectraCure AB (OSTO:SPEC) has a current Total Receivables of kr1.77 Mil. The current Total Receivables is kr1.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For SpectraCure AB (OSTO:SPEC), the current Total Receivables is kr1.77 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpectraCure AB Business Description

Address Magistratsvagen 10, Lund, SWE, 22643
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.